Activity of Matrix Metalloproteinase-7 (MMP-7) Related to Heparin-Binding Epidermal Growth Factor (HB-EGF) Activation in Squamous Cell as Diagnostic Biomarker for Early Detection And Treatment of Maxilarian Cancer: Review Article

Gregorius William Thongiratama, Gede Arya Diva Dhananjaya, Happy Kusuma Mulya, I Made Winarsa Ruma


Background: Squamous cell carcinoma (SCC) has a higher chance of occurance and progression in maxillary sinus cancer than other paranasal sinus cancers (80%). Matrix metalloproteinase-7 (MMP-7) is a protease specified in collagen type IV degradation and Heparin Binding Epidermal Growth Factor activation, which causes an increase in squamous cell carcinoma proliferation and metastasis


Methods: This review aims to identify the potential role of MMP-7 as a target for prevention and therapeutic modality to manage SCC sinus maxillary cancer. We did literature searching in several databases to elucidate the importance of the MMP-7 pathway in SCC sinus maxillary cancer progression.


Results: : Increasing expression and activity of MMP-7 are associated with maxillary sinus cancer progression. Squamous cells, the most impacted in maxillary sinus cancer, sustain dysplasia due to heparin-binding epidermal growth factor (HB-EGF) activation into EGF by MMP-7 and Cluster of Differentiation 44 (CD44) binding complexes that trigger high proliferation and mitogenic activity. The therapeutic function of MMP-7 occurs by affecting the protein 53 (p53) in cancer cell apoptosis initiation by specific interaction with CD44.


Conclusion: MMP-7 could be an alternative therapeutic target and potential treatment option for maxillary sinus cancer. Furthermore, more trials should be done to test the relevancy of MMP-7 uses as an SCC sinus maxillary cancer modality


CD44, HB-EGF, MMP-7, SCC, sinus maxillary cancer

Full Text: View | Download

DOI: 10.33371/ijoc.v18i1.1028

Article Metrics

Abstract View: 75,
PDF Download: 26


Chan J, Yom SS. Nasal cavity and paranasal sinus cancer. In: Handbook of Evidence-Based Radiation Oncology [Internet]. 2018 [cited 2021 Nov 30]. p. 159–69. Available from:

Bossi P, Farina D, Gatta G, Lombardi D, Nicolai P, Orlandi E. Paranasal sinus cancer [Internet]. Vol. 98, Critical Reviews in Oncology/Hematology. Crit Rev Oncol Hematol; 2016 [cited 2021 Nov 30]. p. 45–61. Available from:

Sun Y, Chen Y, Li S, Lei Y, Xu D, Jiang N, et al. NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma. Int J Nanomedicine. 2017;12:6399–412.

Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis [Internet]. 2019;36(3):171–98. Available from:

Chatzipantelis A, Brown SJ, Campbell A. The role of the general dental practitioner in the detection of squamous cell carcinoma of the maxillary antrum. Dent Update. 2018;45(1):71–5.

Elgart K, Faden DL. Sinonasal Squamous Cell Carcinoma: Etiology, Pathogenesis, and the Role of Human Papilloma Virus. Curr Otorhinolaryngol Rep. 2020;8(2):111–9.

Liang Y, Guo S, Zhou Q. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer. Tumor Biol. 2014;35(4):3717–24.

Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs [Internet]. Vol. 31, Journal of Enzyme Inhibition and Medicinal Chemistry. Taylor & Francis; 2016 [cited 2021 Nov 8]. p. 177–83. Available from:

Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T, et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer. 2011;105(6):833–41.

Ke P, Wu Z De, Wen HS, Ying MX, Long HC, Qing LG. Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk. Asian Pacific J Cancer Prev. 2013;14(4):2269–72.

Yao Q, Kou L, Tu Y, Zhu L. MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting. Trends Pharmacol Sci [Internet]. 2018;39(8):766–81. Available from:

Liao HY, Da CM, Liao B, Zhang HH. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem [Internet]. 2021;92(March):9–18. Available from:

Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol [Internet]. 2014 Oct 5 [cited 2021 Nov 6];740:364. Available from: /pmc/articles/PMC4146684/

Hyunsoo JN. How does chemotherapy work- InformedHealth. 2019 Aug 15 [cited 2021 Dec 21];1–4. Available from:

Padma VV. An overview of targeted cancer therapy. BioMedicine [Internet]. 2015 Dec 1 [cited 2021 Dec 21];5(4):1–6. Available from: /pmc/articles/PMC4662664/

Bavi P, Bu R, Uddin S, Al-Kuraya K. MMP7 polymorphisms - A new tool in molecular pathology to understand esophageal cancer. Saudi J Gastroenterol. 2011;17(5):299–300.

Caley MP, Martins VLC, O’Toole EA. Metalloproteinases and Wound Healing. Adv Wound Care. 2015;4(4):225–34.

Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2011;41(2):271–90.

Agarwal P, Ballabh R. Expression of type IV collagen in different histological grades of oral squamous cell carcinoma: An immunohistochemical study. J Cancer Res Ther. 2013;9(2):272.

Lei Z, Jian M, Li X, Wei J, Meng X, Wang Z. Biosensors and bioassays for determination of matrix metalloproteinases: state of the art and recent advances. J Mater Chem B [Internet]. 2020 Apr 29 [cited 2021 Nov 8];8(16):3261–91. Available from:

Goldar S, Khaniani MS, Derakhshan SM, Baradaran B. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pacific J Cancer Prev. 2015;16(6):2129–44.

Kelppe J, Thorén H, Haglund C, Sorsa T, Hagström J. MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases. Clin Exp Dent Res. 2021;7(1):63–9.

Musia K, Zwolińska D. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis. Apoptosis [Internet]. 2011 Jul 23 [cited 2021 Nov 23];16(7):653–9. Available from:

Yu WH, Wu E, Li Y, Hou HH, Yu S su C, Huang PT, et al. Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells. iScience. 2020 Oct 23;23(10):101600.

Mbanefo EC, Kikuchi M, Huy NT, Shuaibu MN, Cherif MS, Yu C, et al. Characterization of a Gene Family Encoding SEA (Sea-urchin Sperm Protein, Enterokinase and Agrin)-Domain Proteins with Lectin-Like and Heme-Binding Properties from Schistosoma japonicum. PLoS Negl Trop Dis [Internet]. 2014 [cited 2021 Nov 24];8(1):e2644. Available from:

Tanikawa C, Zhang Y zhong, Yamamoto R, Tsuda Y, Tanaka M, Funauchi Y, et al. The Transcriptional Landscape of p53 Signalling Pathway. EBioMedicine. 2017 Jun 1;20:109–19.

Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol [Internet]. 2019;20(4):199–210. Available from:

Guo XX, Li Y, Sun C, Jiang D, Lin YJ, Jin FX, et al. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell. 2014;5(3):224–34.

Zaman S, Wang R, Gandhi V. Targeting the Apoptosis Pathway in Hematologic Malignancies. Leuk Lymphoma [Internet]. 2014 [cited 2021 Nov 24];55(9):1980. Available from: /pmc/articles/PMC4152229/

Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, et al. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32(27):3286–95.

Ory B, Ramsey MR, Wilson C, Vadysirisack DD, Forster N, Rocco JW, et al. Erratum: A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma (Journal of Clinical Investigation (2011) 121:2 (809-820) DOI:10.1172/JCI43897). J Clin Invest. 2014;124(3):1418.

Tian J, Hu L, Li X, Geng J, Dai M, Bai X. MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis. J Exp Clin Cancer Res [Internet]. 2016;35(1):1–15. Available from:

Zhang Y, Xu L, Li A, Han X. The roles of ZEB1 in tumorigenic progression and epigenetic modifications. Biomed Pharmacother [Internet]. 2019;110(November 2018):400–8. Available from:

Shaik JA, Reddy RK. Review Article Prevention and Treatment of White Spot Lesions in Orthodontic Patients. Contemp Clin Dent. 2017;8(September):11–9.

Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, et al. P53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol [Internet]. 2011;13(3):317–23. Available from:

Paik WH yu., Song BJ u., Kim HW o., Kim HR e., Hwang JH yeo. MicroRNA-200c as a Prognostic Biomarker for Pancreatic Cancer. Korean J Gastroenterol. 2015;66(4):215–20.

Kumar S, Nag A, Mandal C. A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential. Curr Drug Targets [Internet]. 2015 Oct 14;16(12):1381–403. Available from:

Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25(1):104–13.

Essmann F, Schulze-Osthoff K. Translational approaches targeting the p53 pathway for anti-cancer therapy [Internet]. Vol. 165, British Journal of Pharmacology. Wiley-Blackwell; 2012 [cited 2021 Dec 15]. p. 328–44. Available from: /pmc/articles/PMC3268188/

Zhang LN, Li JY, Xu W. A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia. Cancer Gene Ther. 2013;20(1):1–7.

Kilbride SM, Prehn JHM. Central roles of apoptotic proteins in mitochondrial function [Internet]. Vol. 32, Oncogene. Nature Publishing Group; 2013 [cited 2021 Dec 16]. p. 2703–11. Available from:

Choudhry N, Sarmad S, Waheed NA, Gondal AJ. Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pakistan J Med Sci [Internet]. 2019 [cited 2021 Nov 29];35(1):252–6. Available from: /pmc/articles/PMC6408633/

Bobinskas AM, Wiesenfeld D, Chandu A. Influence of the site of origin on the outcome of squamous cell carcinoma of the maxilla - Oral versus sinus. Int J Oral Maxillofac Surg [Internet]. 2014;43(2):137–41. Available from:

Yang S, Liu C, Hong C, Huang Z, Wang H, Wei L, et al. Autoantibodies against p53 , MMP-7 , and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers. 2021;2021.

Sidorkiewicz I, Niczyporuk M. Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer. 2021;

Board PATE. Paranasal Sinus and Nasal Cavity Cancer Treatment (Adult) (PDQ®). PDQ Cancer Inf Summ [Internet]. 2019 Aug 22 [cited 2021 Nov 6]; Available from:

Praveena NM, Maragathavalli G. Carcinoma of the Maxillary Antrum: A Case Report. Cureus [Internet]. 2018 May 13 [cited 2021 Dec 21];10(5). Available from:

Cancer Research UK. Maxillary sinus cancer TNM stages and grades | Cancer Research UK [Internet]. 2017 [cited 2021 Dec 21]. Available from:

Robbins KT, Ferlito A, Silver CE, Takes RP, Strojan P, Snyderman CH, et al. Contemporary management of sinonasal cancer. Head Neck [Internet]. 2011 Sep 1 [cited 2021 Nov 6];33(9):1352–65. Available from:

Noronha V, Patil VM, Joshi A, Krishna MV, Dhumal S, Juvekar S, et al. Induction Chemotherapy in Technically Unresectable Locally Advanced Carcinoma of Maxillary Sinus. Chemother Res Pract [Internet]. 2014 May 11 [cited 2021 Dec 21];2014:1–6. Available from: /pmc/articles/PMC4037593/

Li K, Ricker K, Tsai FC, Hsieh CJ, Osborne G, Sun M, et al. Estimated cancer risks associated with nitrosamine contamination in commonly used medications. Int J Environ Res Public Health [Internet]. 2021 Sep 1 [cited 2021 Nov 28];18(18). Available from: /pmc/articles/PMC8467924/

Narayan Biswal B, Narayan Das S, Kumar Das B, Rath R. Alteration of cellular metabolism in cancer cells and its therapeutic. J oral Maxillofac Pathol. 2017;21(3):244–51.

D M, B S, P S, K M, Thomas J. Squamous Cell Carcinoma Arising From a Psoriatic Plaque - A Case Report. Int J Dermatopathol Surg [Internet]. 2016 Jan 25 [cited 2021 Nov 30];2(1):24–6. Available from:

Goldenberg A, Ortiz A, Kim SS, Jiang SB. Squamous Cell Carcinoma with Aggressive Subclinical Extension: 5-year Retrospective Review of Diagnostic Predictors. J Am Acad Dermatol [Internet]. 2015 Jul 1 [cited 2021 Nov 30];73(1):120. Available from: /pmc/articles/PMC4475462/

Miyata K, Yotsumoto F, Nam SO, Kuroki M, Miyamoto S. Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer. Anticancer Res. 2012;32(6):2347–52.

Ozbilgin K, Karaca F, Turan A, Köse C, Vatansever S, Ozcakir T. The higher heparin-binding epidermal growth factor (HB-EGF) in missed abortion. Taiwan J Obstet Gynecol. 2015 Feb 1;54(1):13–8.

Saada-Bouzid E, Peyrade F, Guigay J. Molecular genetics of head and neck squamous cell carcinoma. Curr Opin Oncol [Internet]. 2019 May 1 [cited 2021 Dec 15];31(3):131–7. Available from:

Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin Cancer Biol. 2020 Apr;61:71–83.

Tacheva T, Dimov D, Anastasov A, Zhelyazkova Y, Kurzawski M, Gulubova M, et al. Association of the MMP7-181A>G promoter polymorphism with early onset of chronic obstructive pulmonary disease. Balk J Med Genet [Internet]. 2017 Dec 29 [cited 2021 Nov 27];20(2):59–66. Available from:

Yuan S, Lin LS, Gan RH, Huang L, Wu XT, Zhao Y, et al. Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma. BMC Cancer [Internet]. 2020 Jan 14 [cited 2021 Nov 6];20(1). Available from: /pmc/articles/PMC6958600/

Ke B, Fan C, Yang L, Fang X. Matrix Metalloproteinases-7 and Kidney Fibrosis. Front Physiol [Internet]. 2017 Feb 10;8(MAR):3389. Available from:

Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta - Proteins Proteomics [Internet]. 2012;1824(1):146–56. Available from:

Yue L, Shi Y, Su X, Ouyang L, Wang G, Ye T. Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives. Eur J Med Chem [Internet]. 2021;224:113714. Available from:

Liang L, Dong M, Cong K, Chen Y, Ma Z. Correlations of Moesin expression with the pathological stage, nerve infiltration, tumor location and pain severity in patients with pancreatic cancer. J BUON. 2019;24(3):1225–32.

Supit IA, Pangemanan DHC, Marunduh SR. Profil Tumor Necrosis Factor (Tnf-Α) Berdasarkan Indeks Massa Tubuh (Imt) Pada Mahasiswa Fakultas Kedokteran Unsrat Angkatan 2014. J e-Biomedik. 2015;3(2).

Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol [Internet]. 2016;37(9):11553–72. Available from:

Sato S, Drake AW, Tsuji I, Fan J. A Potent Anti-HB-EGF Monoclonal Antibody Inhibits Cancer Cell Proliferation and Multiple Angiogenic Activities of HB-EGF. PLoS One. 2012;7(12):1–12.

Vinante F, Rigo A. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis. Toxins (Basel). 2013;5(6):1180–201.

Vinante F, Rigo A. Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis. Toxins (Basel) [Internet]. 2013 Jun [cited 2021 Nov 30];5(6):1180. Available from: /pmc/articles/PMC3717776/

Lue HW, Yang X, Wang R, Qian W, Xu RZH, Lyles R, et al. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One [Internet]. 2011 Nov 16 [cited 2021 Nov 30];6(11). Available from: /pmc/articles/PMC3218022/

Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R. Interaction of tumor cells with the microenvironment. Cell Commun Signal [Internet]. 2011;9(1):18. Available from:

Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem [Internet]. 2016 Nov 1;31(sup1):177–83. Available from:

Wee P, Wang Z. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basel) [Internet]. 2017 May 17 [cited 2021 Nov 23];9(5). Available from: /pmc/articles/PMC5447962/

Gaffney DC, Soyer HP, Simpson F. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australas J Dermatol. 2014;55(1):24–34.

Sasaki E, Nishikawa D, Hanai N, Hasegawa Y, Yatabe Y. Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion. Histopathology. 2018;73(6):953–62.

Wang S, Zhang J, Wang T, Ren F, Liu X, Lu Y, et al. Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer. Vol. 117, International Journal of Biochemistry and Cell Biology. 2019.

Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol [Internet]. 2011 [cited 2021 Nov 23];12(11):233. Available from: /pmc/articles/PMC3334591/

Jung YS, Liu XW, Chirco R, Warner RB, Fridman R, Kim HRC. TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain. PLoS One [Internet]. 2012 Jun 11 [cited 2021 Nov 23];7(6):38773. Available from: /pmc/articles/PMC3372473/

Vočka M, Langer D, Fryba V, Petrtyl J, Hanus T, Kalousova M, et al. Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer. Int J Biol Markers [Internet]. 2019 Sep 1 [cited 2021 Nov 23];34(3):292–301. Available from:

Wang Q, Gao P, Wang X, Duan Y. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep [Internet]. 2014 [cited 2021 Nov 6];4. Available from:


  • There are currently no refbacks.

Copyright (c) 2024 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.